VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans

BACKGROUND: Candida albicans, the most common human fungal pathogen, causes chronic mucosal infections in patients with inborn errors of IL-17 immunity that rely heavily on chronic, often lifelong, azole antifungal agents for treatment. However, a rise in azole resistance has predicated a need for d...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Antimicrob Chemother
Glavni autori: Break, Timothy J, Desai, Jigar V, Natarajan, Mukil, Ferre, Elise M N, Henderson, Christina, Zelazny, Adrian M, Siebenlist, Ulrich, Hoekstra, William J, Schotzinger, Robert J, Garvey, Edward P, Lionakis, Michail S
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890729/
https://ncbi.nlm.nih.gov/pubmed/29040636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx352
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items